Peninsula biotech moves from IPO to chopping half its workforce in little more than a year
After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...
Truist cuts Cargo Therapeutics rating, slashes PT to $7
Truist Securities revised its position on Cargo Therapeutics (NASDAQ:CRGX), currently trading at $13.19 with a market ...